08/30/2024 | Press release | Distributed by Public on 08/30/2024 15:09
Item 8.01 | Other Events. |
On August 30, 2024, Tonix Pharmaceuticals Holding Corp. (the "Company") increased the maximum aggregate offering price of the shares issuable under its Sales Agreement (the "Sales Agreement") with A.G.P./Alliance Global Partners, dated as of July 30, 2024, from $50,000,000 to $150,000,000. A copy of the legal opinion as to the legality of the shares issuable under the Sales Agreement is filed as Exhibit 5.01 attached hereto.